forecast
CRISPR's first clinical use will target severe congenital disease
CRISPR will likely reach human clinical use first for severe congenital diseases, because patients with horrible conditions make the bar for experimental treatment much lower than for enhancement.
forecastpending
Speaker
Eli DouradoEvidence Quote
“I think it will be used there first”
Source
Eli Dourado - Frontiers for Productivity - [Invest Like the Best, EP. 225]— Invest Like the BestCreated: 11/11/2026, 6:38:30 AM
Your notes
Loading notes...